"Let no man look back and regret that he did nothing for the fear that he would do too little."
Mahatma Gandhi
The treatment effects of electrical stimulation on the brain have been reported since antiquity. 1 However, only 78 years have passed since the first use of electroconvulsive therapy (ECT). A careful examination of the practice of ECT and other neuromodulation techniques should shed light on three areas:
• • the attitudes towards ECT and other neuromodulation techniques;
• • the mounting clinical and research-based evidence;
• • the trends in the practice of these therapies and the approach towards their controversies.
Many things have changed since 1938; however, the lingering stigma of ECT appears to be everlasting. Polarising opinions regarding ECT might have hindered a balanced scientific examination of ECT on one hand and, on the other, it might have deprived the most needy people from accessing an effective treatment.
When ECT is indicated, it is by consensus the most effective treatment in psychiatry. Clinicians, and family who observe patients undergoing ECT, are mostly persuaded by its effectiveness and overall benefits to patient's recovery and quality of life. 2 Often, the level of conviction of a clinician or a family member who observed the response and the journey of recovery of a severely ill patient to ECT is non-debatable. This may be contrasted by agony of the stigma of having ECT and the possible side effects of the procedure. Nevertheless, the most vocal argument that faces any individual who surfs the internet looking for information about ECT is the myriad of figurative depiction of ECT as a 'barbaric treatment'. Surprisingly, many psychiatrists have been, knowingly or unknowingly, affected by such portrayals. This can be observed in the structure and content of some ECT guidelines and legal restrictions. 3 The negative portrayal of ECT may have inspired the development of new treatment modalities such as magnetic seizure therapy (MST), repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS) and deep brain stimulation (DBS). In recent years these treatments have attracted the attention of researchers, clinicians and service providers. With improved techniques and research methodologies, these modalities (Table 1) are progressively finding their places in the stratum of therapies for mental illness.
Of all the neuromodulation techniques, rTMS is currently magnetising more research and utilisation around the world than other modalities. Many studies demonstrated improved effect size with modification of number of parameters in addition to extending the indications to other disorders such as treatment resistant hallucinations. 9 More recently, theta-burst stimulation (TBS), which is a newer form of rTMS protocols, may have a major advantage over standard rTMS in reducing the administration time with similar if not greater effects.
Conventional rTMS sessions last between 20 and 45 min, while TBS sessions require 1-3 min of stimulation. This can potentially alleviate some of the burden of the treatment on patients and their families and can reduce the health cost. 10 At present, transcranial direct or alternate current stimulation (tDCS and tACS, respectively) use in psychiatry is limited to research initiatives in Australia. However, their use in other medical fields is much less restricted. With cautious optimism, these modalities can lend themselves to several indications that may provide more treatment options for specific patient cohorts. There are several unanswered questions; can tDCS/tACS be of any benefit for patients who need maintenance treatments? What are the pros and cons of concomitant use with psychological and cognitive therapies? Further validation is needed to affirm the 'non-invasive' nature of these approaches. Therefore, the enthusiastic endeavour to validate these novel therapies is an invaluable investment because of their 'non-invasiveness', low cost and portability. 1 VNS is another neuromodulatory technique that is found to be useful in many central nervous system disorders, such as refractory epilepsy, chronic pain such as fibromyalgia and pelvic pain, endocrine homeostasis and mood regulation. The techniques include both implantable and external devices. 11 Finally, DBS is the most invasive neuromodulation technique. It involves the stereotactic implantation of unilateral or bilateral electrodes in the brain, connected to a permanently implanted, battery-powered neurostimulator. 12 Several questions are yet to be answered, such as the best target site, the adjustment protocols, predictors of response and elucidating the mode of action for both depression and obsessive compulsive disorder (OCD). 13 In summary, evidence is mounting regarding the validity of the potential novel neuromodulation techniques. Therefore, it is crucial to adopt a balanced strategy to support research in neuromodulation and maintaining healthy optimism. Furthermore, it is prudent to assert the learnt morals from history to refrain from adopting a defensive or reductionist attitude towards or against any of these approaches in a way that restricts innovation and further development of treatment modalities and deprives patients from what can be life-saving treatments. 
